Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marjut Niinivirta
Tumor Endothelial ELTD1 as a Predictive Marker for Treatment of Renal Cancer Patients With Sunitinib
BMC Cancer
Cancer Research
Oncology
Genetics
Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
Journal of Cancer
Oncology
Related publications
Dynamic Changes of Live/Apoptotic Circulating Tumour Cells as Predictive Marker of Response to Sunitinib in Metastatic Renal Cancer
British Journal of Cancer
Cancer Research
Oncology
Circulating Tumor Cells Enumerated by a Centrifugal Microfluidic Device as a Predictive Marker for Monitoring Ovarian Cancer Treatment: A Pilot Study
Diagnostics
Clinical Biochemistry
Sunitinib for Advanced Renal Cell Cancer
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study
Clinical Genitourinary Cancer
Oncology
Urology
A Phase II Trial of Sunitinib in Patients With Renal Cell Cancer and Untreated Brain Metastases
Clinical Genitourinary Cancer
Oncology
Urology
Genetic Polymorphisms as Predictive Biomarker of Survival in Patients With Gastrointestinal Stromal Tumors Treated With Sunitinib
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Hypertension as Predictor of Sunitinib Treatment Outcome in Metastatic Renal Cell Carcinoma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Promoter Methylation of TRIM9 as a Marker for Detection of Circulating Tumor DNA in Breast Cancer Patients
SpringerPlus
Multidisciplinary